Wastewater testing
Ended Definitive Contract Awarded Last action
- Contract number
- 75D30123C17984
- Awardee
-
Verily Life Sciences LLC UEI U92RDNGXL1E5
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $675,039
Award facts
- Opportunity
-
- Request for Information - Wastewater Surveillance Testing Pre-Solicitation · 75D30123R72828 · Posted Jan 19, 2023
- Contract value 2% obligated
-
- $10,607,999.94 Current, with exercised options
- $38,760,799.92 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 9 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- South San Francisco, CA 94080, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Other Administrative Action | -$9,932,961 | |
| Original award | $10,608,000 |
About this award
The Centers for Disease Control and Prevention (CDC) has awarded a $38,760,799.92 firm-fixed-price definitive contract to Verily Life Sciences LLC, a subsidiary of Alphabet Inc., to provide wastewater surveillance testing services. The contract, which has no set-aside designation, will support the CDC's ongoing COVID-19 and monkeypox response efforts, as well as prepare for future public health emergencies. Under the contract, Verily will establish sample collection relationships with wastewater utilities, conduct quantitative PCR testing for SARS-CoV-2 and potential additional pathogens, and submit sequencing and results data to the CDC. The contract has an ultimate completion date of April 22, 2025. This award is part of the CDC's broader efforts to leverage data and technology for public health monitoring, research, and emergency preparedness.
Quick answers
Who was awarded contract 75D30123C17984?
75D30123C17984 was awarded to Verily Life Sciences LLC by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 26, 2023.
How much is contract 75D30123C17984 worth?
The government has obligated $675,039 on 75D30123C17984. Its current value, with exercised options, is $10,608,000. Its potential value, with all options, is $38,760,800.
Was contract 75D30123C17984 competed?
The extent of competition for 75D30123C17984 was full and open competition. The government received 9 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award